Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Gregory

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Urology|October 9, 2003
Androgen receptor gene amplification and protein expression in recurrent prostate cancerO Harris Ford, Christopher W Gregory, Desok Kim, et al.
The American Journal of Pathology|January 12, 2002
Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograftDesok Kim, Christopher W Gregory, Frank S French, et al.
The Prostate|May 3, 2002
Identification of differentially expressed genes associated with androgen-independent growth of prostate cancerJames L Mohler, Tammy L Morris, O Harris Ford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancerMark A Titus, Christopher W Gregory, O Harris Ford, et al.
Human Pathology|October 18, 2005
Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancerQun Lu, Larry J Dobbs, Christopher W Gregory, et al.
The Journal of Biological Chemistry|December 10, 2003
Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancerChristopher W Gregory, Xiaoyin Fei, Liliana A Ponguta, et al.
Experimental and Molecular Pathology|May 10, 2005
Protein C inhibitor (plasminogen activator inhibitor-3) expression in the CWR22 prostate cancer xenograftLaura N Glasscock, Sophie M Réhault, Christopher W Gregory, et al.
Current Urology Reports|June 27, 2002
A novel method for the analysis of the androgen receptorKris E Gaston, O Harris Ford III, Swaroop Singh, et al.
Cancer Research|April 19, 2005
Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancerYuanbo Liu, Samarpan Majumder, Wesley McCall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
The androgen axis in recurrent prostate cancerJames L Mohler, Christopher W Gregory, O Harris Ford, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Urology|October 9, 2003
Androgen receptor gene amplification and protein expression in recurrent prostate cancerO Harris Ford, Christopher W Gregory, Desok Kim, et al.
The American Journal of Pathology|January 12, 2002
Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograftDesok Kim, Christopher W Gregory, Frank S French, et al.
The Prostate|May 3, 2002
Identification of differentially expressed genes associated with androgen-independent growth of prostate cancerJames L Mohler, Tammy L Morris, O Harris Ford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancerMark A Titus, Christopher W Gregory, O Harris Ford, et al.
Human Pathology|October 18, 2005
Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancerQun Lu, Larry J Dobbs, Christopher W Gregory, et al.
The Journal of Biological Chemistry|December 10, 2003
Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancerChristopher W Gregory, Xiaoyin Fei, Liliana A Ponguta, et al.
Experimental and Molecular Pathology|May 10, 2005
Protein C inhibitor (plasminogen activator inhibitor-3) expression in the CWR22 prostate cancer xenograftLaura N Glasscock, Sophie M Réhault, Christopher W Gregory, et al.
Current Urology Reports|June 27, 2002
A novel method for the analysis of the androgen receptorKris E Gaston, O Harris Ford III, Swaroop Singh, et al.
Cancer Research|April 19, 2005
Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancerYuanbo Liu, Samarpan Majumder, Wesley McCall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
The androgen axis in recurrent prostate cancerJames L Mohler, Christopher W Gregory, O Harris Ford, et al.
Pageof 3